PT Prodia Widyahusada Tbk

Jakarta Stock Exchange PRDA.JK

PT Prodia Widyahusada Tbk Shareholders' Equity for the year ending December 31, 2023: USD 153.28 M

PT Prodia Widyahusada Tbk Shareholders' Equity is USD 153.28 M for the year ending December 31, 2023, a 3.76% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

PT Prodia Widyahusada Tbk Shareholders' Equity for the year ending December 31, 2022 was USD 147.72 M, a -6.30% change year over year.
PT Prodia Widyahusada Tbk Shareholders' Equity for the year ending December 31, 2021 was USD 157.66 M, a 25.95% change year over year.
PT Prodia Widyahusada Tbk Shareholders' Equity for the year ending December 31, 2020 was USD 125.18 M, a 4.76% change year over year.
PT Prodia Widyahusada Tbk Shareholders' Equity for the year ending December 31, 2019 was USD 119.49 M, a 10.86% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Jakarta Stock Exchange: PRDA.JK

PT Prodia Widyahusada Tbk

CEO	Ms. Dewi Muliaty
IPO Date	Dec. 9, 2016
Location	Indonesia
Headquarters	Prodia Tower
Employees	2,974
Sector	Healthcare
Industries Dental Care Cleaning Supplies Drugstores & Retail Pharmacies Hospitals & Clinics Medical Instruments Personal Care Telehealth Utilities

Description

PT Prodia Widyahusada Tbk provides private clinical laboratory services. The company offers laboratory, panel test, and other diagnostics support services. As of December 31, 2021, it operated 259 outlets comprising 10 Prodia Health Care and specialty clinic outlets, 142 clinical lab and medical labs, 98 point of care outlets, and 9 hospital collaboration labs in 34 provinces throughout Indonesia. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk is a subsidiary of PT Prodia Utama.

Key trends

Past 5 years